CD80 and neoplasm: Alternatively, Ad5FB4 penton capsomeres, via their negative interference with the B7-H1/B7.1 heterodimer formation, might be used as therapeutic agents to decrease the amounts of these complexes at the tumor cell surface, and hence lower their capacity to resist to anti-tumor T-cell responses.